← Back to Search

Neuromodulation Device

NEUROMARK System for Hay Fever

N/A
Waitlist Available
Research Sponsored by Neurent Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new device called the NEUROMARK System for people with chronic nasal congestion and runny nose. It aims to help those who haven't been helped by usual treatments by targeting the nerves in the nose.

Eligible Conditions
  • Hay Fever

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Efficacy
Safety

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental: TreatmentExperimental Treatment1 Intervention
Subjects will undergo treatment with the NEUROMARK System
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NEUROMARK System
2022
N/A
~40

Find a Location

Who is running the clinical trial?

Neurent MedicalLead Sponsor
4 Previous Clinical Trials
505 Total Patients Enrolled
Annalise SorensenStudy DirectorNeurent Medical
3 Previous Clinical Trials
373 Total Patients Enrolled
~10 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top